Chordia Therapeutics (190A.T) is trading -3.85 percent lower on Monday 26th of October and has a trading volume of JPY 41.3 mn
Chordia Therapeutics trades down 3.85%, JPY 50 a share—biotech firm pursuing cell‑based therapies for ALS and Parkinson’s, 3.9 bn market cap, 52‑week high JPY 179.
- CHORDIA THERAPEUTICS INC
- Japan
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read